Seblewongel ASRAT

Follow

Person

New York, NY, US

People

Patents Grantslast 30 patents

Information Patent Grant
Combination of IL-4/IL-13 pathway inhibitors and plasma cell ablati...
- Patent number 11,964,016
- Issue date Apr 23, 2024
- REGENERON PHARMACEUTICALS, INC.
- Seblewongel Asrat
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
METHODS FOR TREATING EOSINOPHILIC GASTROENTERITIS BY ADMINISTERING...
- Publication number 20240350626
- Publication date Oct 24, 2024
- Regeneron Pharmaceuticals, Inc.
- Seblewongel ASRAT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION OF IL-4/IL-13 PATHWAY INHIBITORS AND PLASMA CELL ABALAT...
- Publication number 20240350625
- Publication date Oct 24, 2024
- Regeneron Pharmaceuticals, Inc.
- Seblewongel ASRAT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods Of Mapping Antigen Specificity To Antibody-Secreting Cells
- Publication number 20230349919
- Publication date Nov 2, 2023
- Regeneron Pharmaceuticals, Inc.
- Brian Klotz
- G01 - MEASURING TESTING
Information Patent Application
COMBINATION OF IL-4/IL-13 PATHWAY INHIBITORS AND PLASMA CELL ABLATI...
- Publication number 20200345843
- Publication date Nov 5, 2020
- Regeneron Pharmaceuticals, Inc.
- Seblewongel ASRAT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE